Subsequently, both 2116 LILRB1 and CD19 CAR-T cells killed B-ALL PDX cells expressing luciferase with similar efficacy, while 2115 LILRB1 CAR-T cells did not exhibit any advantage over MOCK T cells (Fig. 5E). This evidence concerns the gene CD19 and acute lymphoblastic leukemia.